ATE414164T1 - Verfahren zur kontrolle der spaltung mit ompt protease - Google Patents

Verfahren zur kontrolle der spaltung mit ompt protease

Info

Publication number
ATE414164T1
ATE414164T1 AT00906696T AT00906696T ATE414164T1 AT E414164 T1 ATE414164 T1 AT E414164T1 AT 00906696 T AT00906696 T AT 00906696T AT 00906696 T AT00906696 T AT 00906696T AT E414164 T1 ATE414164 T1 AT E414164T1
Authority
AT
Austria
Prior art keywords
amino acid
polypeptide
ompt protease
site
amino acids
Prior art date
Application number
AT00906696T
Other languages
English (en)
Inventor
Kazuaki Okuno
Masayuki Yabuta
Kazuhiro Ohsuye
Original Assignee
Asubio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asubio Pharma Co Ltd filed Critical Asubio Pharma Co Ltd
Application granted granted Critical
Publication of ATE414164T1 publication Critical patent/ATE414164T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AT00906696T 1999-03-04 2000-03-03 Verfahren zur kontrolle der spaltung mit ompt protease ATE414164T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5773199 1999-03-04

Publications (1)

Publication Number Publication Date
ATE414164T1 true ATE414164T1 (de) 2008-11-15

Family

ID=13064080

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00906696T ATE414164T1 (de) 1999-03-04 2000-03-03 Verfahren zur kontrolle der spaltung mit ompt protease

Country Status (12)

Country Link
US (1) US7344856B1 (de)
EP (1) EP1076097B1 (de)
JP (1) JP4471501B2 (de)
KR (1) KR100916169B1 (de)
CN (1) CN100445394C (de)
AT (1) ATE414164T1 (de)
AU (1) AU758633B2 (de)
CA (1) CA2327524C (de)
DE (1) DE60040771D1 (de)
ES (1) ES2316352T3 (de)
IL (1) IL139338A0 (de)
WO (1) WO2000052193A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL162780A0 (en) * 2002-04-11 2005-11-20 Kenji Kangawa Method for producing modified peptide
ES2398463T3 (es) * 2003-09-30 2013-03-19 Daiichi Sankyo Company, Limited Método de escisión de polipéptidos usando un mutante de la proteasa OmpT
US8586294B2 (en) 2004-05-18 2013-11-19 The Board Of Trustees Of The Leland Stanford Junior University Detection of protein translocation by beta-galactosidase reporter fragment complementation
US8030447B2 (en) 2006-09-20 2011-10-04 The Board Of Regents Of The University Of Texas System Substrate peptide sequences for plague plasminogen activator and uses thereof
CN102707054B (zh) * 2012-06-18 2014-11-05 黑龙江八一农垦大学 大肠埃希氏菌OmpT抗体间接ELISA检测方法
AU2013329464C1 (en) * 2012-10-12 2018-02-15 Sutro Biopharma, Inc. Proteolytic inactivation of select proteins in bacterial extracts for improved expression
WO2020061257A2 (en) * 2018-09-19 2020-03-26 Georgia Tech Research Corporation Biological bits as computable elements within living systems

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037145A (en) * 1994-09-07 2000-03-14 Suntory Limited Process for production of protein
WO1998049286A2 (en) * 1997-05-01 1998-11-05 Board Of Regents, The University Of Texas System Directed evolution of enzymes and antibodies
DK0978565T3 (da) 1998-01-30 2008-02-04 Asubio Pharma Co Ltd Fremgangsmåde til fremstilling af peptid under anvendelse af et hjælperpeptid

Also Published As

Publication number Publication date
EP1076097A1 (de) 2001-02-14
EP1076097B1 (de) 2008-11-12
KR100916169B1 (ko) 2009-09-08
CA2327524C (en) 2010-02-02
AU758633B2 (en) 2003-03-27
JP4471501B2 (ja) 2010-06-02
ES2316352T3 (es) 2009-04-16
EP1076097A4 (de) 2003-02-05
WO2000052193A1 (fr) 2000-09-08
KR20010043333A (ko) 2001-05-25
CA2327524A1 (en) 2000-09-08
IL139338A0 (en) 2001-11-25
DE60040771D1 (de) 2008-12-24
CN100445394C (zh) 2008-12-24
AU2828800A (en) 2000-09-21
US7344856B1 (en) 2008-03-18
CN1302337A (zh) 2001-07-04

Similar Documents

Publication Publication Date Title
ATE124456T1 (de) Verfahren zur enzymatischen spaltung rekombinanter proteine unter verwendung von iga- proteasen.
DE3586773D1 (de) Verfahren zur beseitigung von n-endaminosaeureresten aus eukaryotpolypeptidanlagen und so erzeugte polypeptide.
DE60018909D1 (de) Neue carbonyl-reduktase, gen davon und verfahren der anwendung derselben
DK1144607T5 (da) Fremgangsmåde til præsentation af (poly)peptider/proteiner på bakteriofage partikler via disulfidbindinger
HUT54213A (en) Process for the enzymatic removal of n-terminal sequence of proteins
DE60320362D1 (de) Verfahren zur Herstellung von Dipeptiden
ATE110414T1 (de) System zur bearbeitung von hefe, welches eine zur bearbeitungsstelle benachbarte negativ geladene aminosäure beeinhaltet.
DE60309865D1 (de) Glycoprotein vi - fc fusions protein zur behandlung von gefässerkrankungen
DE3856362D1 (de) Regelung von elektrostatischen interaktionen an metallionen-bindungsstellen zur stabilisierung von proteinen
DE50204952D1 (de) Verfahren zur herstellung von rekombinantem trypsin
ATE341640T1 (de) Verfahren zur herstellung von nicht-proteinogenen l-aminosäuren
DE60040771D1 (de) Verfahren zur kontrolle der spaltung mit ompt protease
DE602004032345D1 (de) Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen
DE69739013D1 (de) Verfahren zur Herstellung sekretorischer KEX2-Derivate
NO930428D0 (no) Proteinstrukturen til plantetoksingelonin
ATE253639T1 (de) Verfahren zur herstellung von peptiden
DK1095141T3 (da) Fremgangsmåde til fremstilling af et peptid med pI-værdi over 8 eller under 5
DE59712235D1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
DE60037508D1 (de) Verfahren zur herstellung von rekombinantem insulin durch fusionsproteine
DE69732583D1 (de) Verfahren zur Spaltung eines chimeren Proteins mittels eines 'processing'-Enzyms
EP0330700A4 (de) Menschlicher Prourokinase ähnliches Polypeptid.
ATE389010T1 (de) Verfahren zur herstellung von optisch aktiven pyridinethanol-derivaten
DE60327228D1 (de) Verfahren zur herstellung von wachstumshormon und antagonisten davon mit geringeren konzentrationen an isoformen verunreinigungen davon
NO900410L (no) Fremgangsmaate til produksjon av glukagon.
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1076097

Country of ref document: EP